1.02310

PARTECK® CCS Croscarmellose Sodium

EMPROVE® ESSENTIAL, Ph. Eur., JP, NF

Manufacturer: SAFC

CAS Number: 74811-65-7

Synonym(S): PARTECK® CCS Croscarmellose Sodium

Select a Size

Pack Size SKU Availability Price
0.5 KG 1.02310-0.5-KG In Stock ₹ 20,657.35

1.02310 - 0.5 KG

₹ 20,657.35

In Stock

Quantity

1

Base Price: ₹ 20,657.35

GST (18%): ₹ 3,718.323

Total Price: ₹ 24,375.673

Agency

JPNFPh. Eur.

Quality Level

500

product line

EMPROVE® ESSENTIAL

form

fine powder

pH

5-7 (20 °C, 10 g/L in H2O)

solubility

30 g/L

application(s)

pharmaceuticalsolid formulation

storage temp.

2-30°C

Other Options

Image Product Name Manufacturer Price Range
Croscarmellose sodium
-- ₹ 16,984.43
Croscarmellose sodium
-- ₹ 44,436.63
PARTECK® CCS Croscarmellose Sodium
-- ₹ 20,657.35
PARTECK® CCS Croscarmellose Sodium
-- ₹ 20,657.35
74811-65-7 | Croscarmellose Sodium
-- ₹ 7,031.00 - ₹ 67,017.00

Related Products

Img

Supelco

1.93631

EMPLURA®...

Img

Supelco

1.93642

EMPLURA®...

Img

SAFC

1.06360

EMPROVE® ESSENTIAL, Ph. Eur., BP, J...

Img

Supelco

1.93614

EMPLURA®...

Img

SAFC

1.06323

EMPROVE® ESSENTIAL, Ph. Eur., BP, C...

Img

SAFC

1.72577

for table water, FCC, E 500...

Img

Sigma Aldrich

10029

puriss., ≥98%...

Img

SAFC

1.06642

crystalline, EMPROVE® ESSENTIAL, Ph...

Description

  • General description: With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
  • Application: Parteck® CCS excipient is a superdisintegrant for oral pharmaceutical formulations. Its unique swelling properties shorten tablet disintegration time, thereby increasing disintegration efficiency. Parteck® CCS is highly flexible and suitable for use in capsule formulation, wet granulation, roller compaction and direct compression.
  • Features and Benefits: Fast disintegration Rapid water absorption Good tablet dissolution for a wide variety of applications Does not contain peroxides – for better API stability Flexible in use Very well suited for direct compression, roller compaction, wet granulation and capsule technologies.
  • Legal Information: Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable